Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 209 publications
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study.
Journal: The Journal of rheumatology
Published: April 01, 2026
Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.
Journal: The Journal of rheumatology
Published: April 01, 2026
Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.
Journal: The Journal of rheumatology
Published: April 01, 2026
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study.
Journal: The Journal of rheumatology
Published: April 01, 2026
A highly prevalent lupus risk haplotype increases IRF7-dependent induction of IFN-α, enhancing antiviral defense and exacerbating autoimmunity.
Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026
Psychometrics of inflammatory back pain criteria in the US population.
Journal: EULAR rheumatology open
Published: January 09, 2026
Impact of comorbidities and extra-musculoskeletal manifestations on radiographic progression in ankylosing spondylitis.
Journal: Rheumatology (Oxford, England)
Published: November 18, 2025
Multi-omic insights from a multi-ancestry genome-wide meta-analysis of ankylosing spondylitis reveal novel pathways of disease susceptibility.
Journal: Research square
Published: July 25, 2025
Global epidemiology of spondyloarthritis.
Journal: Nature reviews. Rheumatology
Published: July 03, 2025
Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration.
Journal: Advances in therapy
Published: May 05, 2025
Individualizing NSAID therapy in axial spondyloarthritis: N-of-1 trials with Bayesian analysis.
Journal: Rheumatology (Oxford, England)
Published: April 25, 2025
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials.
Journal: Rheumatology and therapy
Published: April 18, 2025
Last Updated: 09/26/2026